Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest UCLA's Jonsson Comprehensive Cancer Center Stories

2012-08-05 18:21:55

Industry-Academic Partnership Will Establish New Research Center to Expedite Study and Development of Gene Transfer Approach PHILADELPHIA, Aug. 6, 2012 /PRNewswire-USNewswire/ -- In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric...

2012-07-17 14:21:13

LOS ANGELES, July 17, 2012 /PRNewswire-USNewswire/ -- Ronald Reagan UCLA Medical Center ranks among the top five American hospitals, according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors. The medical center also was rated the best hospital in the western United States for the 23rd consecutive year and the No. 1 hospital in the Los Angeles metropolitan area and the state of California. "Our purpose...

2012-06-12 11:44:55

-People newly diagnosed with chronic leukemia must often wait to learn if they have a faster- or slower-progressing form of the disease. -This study identified a molecular marker that quickly helps to distinguish which form a patients has. -The findings could enable patients with aggressive disease to start treatment sooner. Researchers have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment...

2012-05-18 14:20:31

LOS ANGELES, May 18, 2012 /PRNewswire-USNewswire/ -- Urologic conditions like urinary tract infections, kidney stones, and prostate cancer are a major economic burden on Americans, resulting in health care costs of close to $40 billion annually, according to a newly released national report that charts the demographic and economic impact of urologic diseases in the U.S. Urologic Diseases in America (UDA), last published in 2007, has been revised and updated for 2012 and includes a wealth of...

2012-03-06 22:51:59

Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it. Now, researchers at UCLA's Jonsson Comprehensive Cancer Center have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene. By examining the part of the melanoma genome that encodes proteins, called the exome, Jonsson Cancer Center scientists discovered that in some patients with BRAF-mutated metastatic melanoma, the...

2012-02-23 10:15:37

Researchers from UCLA's Jonsson Comprehensive Cancer Center, together with scientists from 12 other sites in the United States and Australia, report for the first time that a newly approved drug for patients with metastatic melanoma nearly doubles median survival times, a finding that will change the way this deadly form of skin cancer is treated. The data comes from an international Phase II study of Zelboraf that included 132 patients followed for at least one year. Patients with this...

2012-02-14 11:28:40

Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don't respond well to chemotherapy. Now, researchers with the UCLA Department of Radiation Oncology at UCLA's Jonsson Comprehensive Cancer Center report for the first time that radiation treatment —despite killing half of all tumor cells during every treatment - transforms other cancer cells into treatment-resistant breast cancer stem cells. The...

2012-01-24 12:05:00

PITTSBURGH, Jan. 24, 2012 /PRNewswire/ -- Precision Therapeutics, Inc. has recently expanded their BioSpeciFx® product to include 21 clinically-relevant biomarkers to help physicians with their treatment decisions. This enhances Precision's approach to personalizing cancer care by offering additional molecular markers, including the recently FDA-approved ALK-FISH test. By utilizing BioSpeciFx® results in combination with Precision Therapeutics' ChemoFx® in vitro drug response...

2012-01-23 13:28:05

Quality of life in younger patients treated for breast cancer is seriously compromised and these women suffer from severe psychological distress, infertility, premature menopause, a decrease in physical activity and weight gain, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center. The study, published in the peer-reviewed Journal of the National Cancer Institute, found that the mental issues faced by younger breast cancer survivors were more serious than the...

2011-12-01 11:33:15

U-M pilot study examined systematic genetic screening for patients with advanced or treatment-resistant cancer As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments. The University of Michigan Comprehensive Cancer Center and Michigan Center for Translational Pathology (MCTP) recently completed a pilot study aimed at solving the practical challenges involved in quickly and...